NAUT FY 2020 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$289M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$16M

Net Income

-$16M

EPS (Diluted)

$-0.47

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$369,000

Balance Sheet

Total Assets

$85M

Total Liabilities

$115M

Stockholders' Equity

-$30M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	$0	—
Operating Income	-$16M	-$10M	-55.7%
Net Income	-$16M	-$10M	-62.4%